Download FREE Report Sample
Download Free sampleMetabotropic Glutamate Receptor 4 Market contains market size and forecasts of Metabotropic Glutamate Receptor 4 in global, including the following market information:
Global Metabotropic Glutamate Receptor 4 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Metabotropic Glutamate Receptor 4 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Metabotropic Glutamate Receptor 4 companies in 2021 (%)
The global Metabotropic Glutamate Receptor 4 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
VU-0418506 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Metabotropic Glutamate Receptor 4 include Addex Therapeutics Ltd, Domain Therapeutics SA and Prexton Therapeutics SA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metabotropic Glutamate Receptor 4 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metabotropic Glutamate Receptor 4 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Metabotropic Glutamate Receptor 4 Market Segment Percentages, by Type, 2021 (%)
VU-0418506
ADX-88178
JBPOS-0101
PXT-2331
Others
Global Metabotropic Glutamate Receptor 4 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Metabotropic Glutamate Receptor 4 Market Segment Percentages, by Application, 2021 (%)
Anxiety Disorders
Autism
Depression
Drug Addiction
Others
Global Metabotropic Glutamate Receptor 4 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Metabotropic Glutamate Receptor 4 Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metabotropic Glutamate Receptor 4 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Metabotropic Glutamate Receptor 4 revenues share in global market, 2021 (%)
Key companies Metabotropic Glutamate Receptor 4 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Metabotropic Glutamate Receptor 4 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Addex Therapeutics Ltd
Domain Therapeutics SA
Prexton Therapeutics SA
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy